Alzheimer ’ s Disease Diagnostic Market 2016 : Market Segments , Landscape , Company Profiles , Demand and Forecast – 2022
Market Highlights
Alzheimer ’ s is a type of dementia which causes failure of the functioning of the brain . This disease damages the areas which is responsible for the thinking , problem solving and behavior process . According to the Alzheimer ’ s association , more than 5 million are living with Alzheimer ’ s and one out of three seniors dies with the Alzheimer ’ s or any another type of dementia .
One of the most common early symptoms of Alzheimer ' s is difficulty remembering newly learned information . As the Alzheimer ' s advances through the brain it leads to increasingly severe symptoms which include bafflement , mood and behavior swings , deepening confusion about events , time and place ; unfounded thoughts about family , friends and professional caregivers and more serious memory loss and behavior changes ; and difficulty speaking , swallowing and walking .
There are different types of tests to diagnose the symptoms of the Alzheimer ’ s which includes Mini Mental State Exam ( MMSE ) this tests will help to know whether there are problems with the areas of brain involved in learning , memory , thinking , or planning skills . Other one is brain imaging which includes CT scan , Magnetic Resonance Imaging ( MRI ); Neuropsychological Testing and genetic tests which provide information regarding the incorrect linking of the genes which causes Alzheimer ’ s among others .
Request a Sample Report @ https :// www . marketresearchfuture . com / sample _ request / 2149 Key Players :
� Eli Lilly and Company ( UK ), � TauRx ( Republic of Singapore ), � Alector LLC ( US ), � Accera , Inc . ( US ),
Tel : + 1-646-845-9349 sales @ marketresearchfuture . com